Drug Metabolism/Pharmacology

Top Story

Acetaminophen undetectable in more than half of related DILI cases

February 11, 2019

CAMP4, Alnylam partner to identify rare liver disease genetic targets

January 24, 2019
CAMP4 Therapeutics and Alnylam Pharmaceuticals announced a collaboration designed to identify new medication targets of an undisclosed rare liver disease with…
Meeting News

Zinc combination therapy shows slight trend toward survival benefit in alcoholic hepatitis

November 13, 2018
SAN FRANCISCO — Combination therapy with Kineret, Trental and zinc sulfate showed only a slight trend toward 90-day improved survival in patients with alcoholic…

BioIVT research links BSEP inhibition with bile acid suppression in DILI

September 12, 2018
BioIVT announced results of their research into cholestatic drug-induced liver injury and the BSEP bile acid transporter, according to a press release. The data showed…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

VIDEO: Physicians must directly discuss complementary medications

November 16, 2017
More »
Healio Jobs